Maynard Um
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Oppenheimer
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Deutsche Bank
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at BofA Securities
-
-
-
-
-
-
-
Wolfe Research Starts Acadia Pharmaceuticals (ACAD) at Outperform
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Stifel
-
443,846 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

